DRRX 241115 3.00C (DRRX241115C3000) Stock Options, News & Quotes

US OptionsDetailed Quotes

DRRX241115C3000

Watchlist

0.05
0.000.00%

15min DelayClose Nov 4 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Durect Corp Annual Meeting Decisions and Shareholder Votes
TipRanksSep 26 17:00 ET
Durect Agreement on Larsucosterol Trial 'a Major Positive,' Says Northland
TipRanksSep 26 09:00 ET
Durect Analyst Ratings
BenzingaSep 26 06:38 ET · Ratings
Express News | DURECT Corp - Phase 3 Trial to Enroll 200 U.S. Patients
ReutersSep 25 08:00 ET
Express News | DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-Associated Hepatitis
ReutersSep 25 08:00 ET
KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer
BusinesswireSep 4 08:00 ET

Comments

Jaguar8

Oct 16 15:46

Form 4

$Durect (DRRX.US)$

Jaguar8

Sep 25 07:06

NEWS

$Durect (DRRX.US)$
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
Type B meeting with FDA held under Breakthrough Therapy designation resulted in agreement on key aspects of Phase 3 trial design
- Single Phase 3 trial designed to enroll 200 U.S. patients with a 90-day survival primary endpoint;topline results expected within two years of trial initiation
- Protocol for Phase 3 trial builds on data from the AHFIRM Phase 2b tr...

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Trytosaveabit

May 21 07:02

News

$Durect (DRRX.US)$ Reuters· 1 min ago
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis